T 1388/22 of 08.08.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T138822.20240808
- Date of decision
- 8 August 2024
- Case number
- T 1388/22
- Petition for review of
- -
- Application number
- 11801741.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibodies against human CD39 and use thereof
- Applicant name
- Orega Biotech
INSERM - Institut National de la Santé et de la
Recherche Médicale - Opponent name
- AbbVie Inc.
Tizona Therapeutics
D Young & Co LLP
Boult Wade Tennant LLP - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 100(1)European Patent Convention R 84(1)
- Keywords
- Lapse of patent in all designated states - continuation of appeal proceedings (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.